SeaStar Medical Holding Corporation announced a 1-for-10 reverse stock split to increase the market price for its common stock.
The reverse split will be effective on January 5, 2026, on The Nasdaq Capital Market under the ticker symbol 'ICU'.
Stockholders will receive information on their share ownership post the reverse stock split.
Objective of Reverse Split
Increase market price for compliance with Nasdaq rules and enable the Company to regain compliance with the $1.00 minimum bid price requirement.
Stock Conversion Ratio
Each 10 pre-split shares of common stock will convert to 1 issued share, reducing the number of shares and adjusting exercise prices of outstanding options and warrants.
Shareholder Action
Stockholders will receive one whole share in lieu of fractional shares and will have positions adjusted automatically for the reverse split.
- The reverse split aims to boost the market price of SeaStar Medical's common stock and meet Nasdaq listing requirements.
- Stockholders will see a reduction in the number of outstanding shares and changes in exercise prices of options and warrants post the reverse split.
SeaStar Medical's reverse split marks a strategic move to enhance its market position and align with Nasdaq regulations, impacting shareholder holdings and trading conditions.